Related Experiment Videos
Mood-elevating effect of captopril in depressed patients
The American Journal of Psychiatry
|January 1, 1984
Summary
Captopril, an angiotensin-converting enzyme and enkephalinase inhibitor, significantly improved mood in three depressed patients. Further research into neuropeptide synthesis modulators may offer new treatments for neuropsychiatric disorders.
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- Depression is a complex neuropsychiatric disorder with various underlying mechanisms.
- Angiotensin-converting enzyme (ACE) and enkephalinase are enzymes involved in neuropeptide metabolism.
Observation:
- Three patients diagnosed with depression experienced notable mood elevation.
- This mood improvement coincided with the administration of captopril.
Findings:
- Captopril, an inhibitor of both angiotensin-converting enzyme and enkephalinase, demonstrated a positive effect on mood.
- The observed mood elevation suggests a potential role for ACE and enkephalinase inhibition in managing depressive symptoms.
Implications:
- Substances that modulate neuropeptide synthesis or degradation are promising therapeutic candidates for neuropsychiatric conditions.
- Further investigation into captopril and similar agents could lead to novel antidepressant strategies.
- This study highlights the potential of targeting neuropeptide pathways for treating mood disorders.